Feb 08, 2021
Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Feb 03, 2021
Sana Announces Upsized Pricing of Initial Public Offering
Jan 08, 2021
Sana Biotechnology Announces Appointments to its Board of Directors
Jan 06, 2021
Sana Biotechnology Builds Key Regulatory Capabilities as Ke Liu, M.D., Ph.D., Joins Senior Leadership Team